Case Report
Version 1
Preserved in Portico This version is not peer-reviewed
Treatment of Covid-19 with Minocycline and a Guanosine-Restricted Diet: Case Report
Version 1
: Received: 18 December 2020 / Approved: 23 December 2020 / Online: 23 December 2020 (15:58:38 CET)
How to cite: Baranowitz, S.; Nrekaj, M. Treatment of Covid-19 with Minocycline and a Guanosine-Restricted Diet: Case Report. Preprints 2020, 2020120596. https://doi.org/10.20944/preprints202012.0596.v1 Baranowitz, S.; Nrekaj, M. Treatment of Covid-19 with Minocycline and a Guanosine-Restricted Diet: Case Report. Preprints 2020, 2020120596. https://doi.org/10.20944/preprints202012.0596.v1
Abstract
We report the treatment of a 21-year-old female Covid-19 patient by a novel combination of minocycline and a guanosine-restricted diet. Minocycline is an antibiotic with well documented broad spectrum anti-viral effects, including evidence of activity against SARS-CoV-2. Deprivation of guanosine has been documented as an effective anti-viral modality in vitro and in animal models, and specific in vitro activity against CoV-SARS-2 has been reported. The patient's symptoms resolved rapidly.
Keywords
Covid-19, SARS-CoV-2, drug repurposing
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment